No Data
No Data
Chongqing Taiji Industry (600129.SH): The state-owned equity of the indirect controlling shareholder is transferred without compensation.
On January 13, Glonghui reported that Chongqing Taiji Industry (600129.SH) announced that the company received a reply from China National Pharmaceutical Group ("Reply on Agreeing to Transfer 66.6666% of Chongqing Taiji Industry's Shares for Free"), in order to implement the requirements of the State-owned Assets Supervision and Administration Commission regarding deepening the reform actions of state-owned enterprises and further clarifying the relationship between property ownership and management levels. China National Pharmaceutical Group agreed to transfer its 66.6666% shares held in Chongqing Taiji Industry to its actual controller, China National Pharmaceutical Group, without compensation. China National Pharmaceutical and China National Pharmaceutical Group have signed an agreement regarding the free transfer of 66.6666% of Chongqing Taiji Industry's shares.
Chongqing Taiji Industry(Group) Co.,Ltd (SHSE:600129) Delivered A Better ROE Than Its Industry
Chongqing Taiji Industry (600129.SH): Amoxicillin dispersible tablets have passed the generic drug consistency evaluation.
Chongqing Taiji Industry (600129.SH) announced that its holding subsidiary Southwest Pharmaceutical Co., Ltd. (abbreviated as: ...
Chongqing Taiji Industry Gets Macau Chinese Patent Medicine Registration for Huagai Granules
Chongqing Taiji Industry (600129.SH): Huagai granules have obtained the registration certificate for Chinese Patent Medicine in Macau.
On January 3, Gronghui reported that Chongqing Taiji Industry (600129.SH) announced that on January 2, 2025, its wholly-owned subsidiary, Taiji Group Macau Pharmaceutical Research Institute Co., Ltd. (referred to as: Macau Company), received the "Chinese Patent Medicine Registration Certificate" from the Macau Pharmaceutical Supervisory Authority for Huagai Granules【Taiji】(specification: 4.13g per bag). The prescription for this product comes from the Song Dynasty's "Tai Ping Hui Min He Ji Ju Fang" and is listed in the "Catalogue of Ancient Classic Formulas (First Batch)" published by the National Administration of Traditional Chinese Medicine, used for respiratory system medications. Its indicated functions are: to diffuse the lungs and relieve the exterior, to eliminate phlegm and stop cough. It is used for lung cold pathogens and cough.
Chongqing Taiji Industry to Buy Two Local Peers